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Abstract: Background — The presence of chronic hard-to-heal wounds significantly affects patients’ quality of life causing pain, discomfort, 
decrease of mobility and consequently leads to social isolation and depression. This type of wound is more prevalent among older 
population. It has been estimated that up to 1-2% of the world population have this condition. The treatment of hard-to-heal wounds is 
expensive and long-term process, and, stresses healthcare systems of every country. Unfortunately, limited information is available about 
the situation with chronic wounds in Kazakhstan as the statistical data on such patients is not monitored and not registered in this country. 
Methods — The search was conducted by using available electronic sources, including Google Scholar, PubMed, Web of Sciences, Medline, 
Wiley Online Library, and Cochrane Library databases as well as hard copy versions of peer-reviewed publications in Russian, Kazakh, and 
English languages.  
Results — We have identified and analyzed current situation with wound care in the Republic of Kazakhstan. Research has demonstrated a 
variety of types of treatments utilized in the country, particularly the treatment of the diabetic foot.It also indicates the lack of statistics on 
wound care. 
Conclusions — The review highlights the mechanisms of wound healing process, methods for wound care, and encompasses the 
information available on wound healing in Republic of Kazakhstan. The article emphasizes the necessity of establishing the systemic 
monitoring of wound care and formation of electronic database. Apart from that, the importance of developing and manufacturing of 
domestic novel wound treatments have been also stressed out. 
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Introduction  
Chronic ulcers represent a great burden to healthcare systems 
worldwide. The estimated number of people suffering from this 
condition reaches 1-2% of world population [1]. Although there is 
no agreed definition of chronic wounds, they have been usually 
described as wounds that were not able to heal within a certain 
period of time [1, 2]. The major types of chronic wounds are 
venous leg ulcer, diabetic foot, and pressure ulcer [1]. These 
wounds are mostly prevalent in older population and are often 
caused by underlying health problems such as diabetes, vascular 
diseases, or obesity [1, 3, 4].  
For Kazakhstan, no collection of data for statistical analysis on 
the prevalence of chronic wounds has been conducted for the 
whole country. Therefore, several reports of doctors from 
different regions of Kazakhstan were referring to the number of 
patients accepted annually in local hospitals to describe the 
prevalence of hard-to-heal wounds. For example, Negemedjanov 
[5] wrote that around 17-19 patients with chronic wounds were 
treated annually in Petropavlovsk hospital. However, since not 
every hospital accepts and treats chronic ulcers, a rough 
assumption on the prevalence can only be made based on the 
number of people with diabetes in Kazakhstan. The prevalence of 
diabetes increased up to 1.6 times between 2000 and 2010 [6]. In 
2013, there were around 526,010 cases of diabetes in adults in 
Kazakhstan [7]. It is estimated that around 25% of patients with 
diabetes develop chronic ulcers during their life [8]. Thus, it may 
be roughly assumed that at the moment more than 130 thousand 
people with diabetes in Kazakhstan may have or will develop 
chronic skin ulcers. Moreover, this number may increase over time 
due to the growth of general and older population size.  
This is the first review article that is written with the purpose 
of increasing public awareness and describing the current situation 
of chronic wound care in Kazakhstan. 
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Table 1. Details of the search strategy  
Searched words Sources and places of search 
Wound, 
chronic wound,  
septic wound,  
trophic ulcer,  
bed sores,  
diabetic foot, 
leg ulcer, 
Kazakhstan 
Journals 
Consilium*, Medicine*, Vestnik KazNMU*, KazNU Bulletin Biology series*, Astana Medical Journal*, 
Terapevticheskyi Vestnik*, Vestnik Hirurgii Kazahstana, Aktual'nye voprosy formirovanija zdorovogo 
obraza zhizni, profilaktiki zabolevanij i ukreplenija zdorov'ja, Farmatsiya Kazakhstana, Vestnik Evraziyskogo 
natsional'nogo universiteta, Densawli'k 
Libraries National Academic Library of the Republic of Kazakhstan*, Nazarbayev University Library* 
Databases 
Web of Science, PubMed, Cochrane Library, Wiley Online Library, Medline, Google Scholar, 
www.articlekz.com 
Websites 
www.dari.kz, www.zdrav.kz, www.e-library.kz, Journal of Clinical Medicine of Kazakhstan*, East 
Kazakhstan Regional Library (www.pushkinlibrary.kz), Republican Scientific and Technical Library 
(www.rntb.kz), www.google.com 
* Sources that contained necessary articles or information that was included in this review. 
 
 
Figure 1. Inclusion and exclusion criteria of the articles found 
 
 
Material and Methods 
Search strategy 
The search was conducted online using Google Scholar, 
PubMed, Web of Sciences, Medline, Wiley Online Library, and 
Cochrane Library databases and hard copy versions of peer-
reviewed publications in Russian, Kazakh, and English languages. 
The search of hard copies was restricted to libraries in the Astana 
city. The keywords for search were: wound, chronic wound, septic 
wound, trophic ulcer, bed sores, diabetic foot, leg ulcer, and 
Kazakhstan. Table 1 shows words used for search and sources of 
articles. None of the well-known databases revealed papers of 
interest related specifically to Kazakhstan. The websites have 
limited information most of which is not referenced or contains 
student dissertations with restricted or no access.  
Figure 1 demonstrates inclusion and exclusion criteria and the 
number of articles found in each category. Note that only one 
review articles was found, but it was not included because it was 
not related to Kazakhstan. Most of the articles were case studies 
conducted in hospitals with no reference to previous studies in 
vitro or in vivo or to their ethical approval. 
 
Ethics issues 
The conducted research did not involve any human subjects, 
including human material or human data.The research was solely 
restricted to available data bases: electronic and printed. 
 
Wound healing and its mechanism 
A wound healing is complex by nature and the processes 
underlying it are not well understood to the date. Healing of 
normal wound is usually described in three [9, 10] or four 
overlapping stages (depending on the source of the information) 
[3, 4, 11]: homeostasis, inflammation, proliferation, and 
remodeling. A normal woundstuck in the inflammation phase and 
unable to proceed to further stages of healing in a certain period 
of time becomes chronic [10]. During a prolonged inflammation 
phase the inflammatory cytokines and white blood cells not only 
debride wound of necrotic tissue and bacteria, but can also 
damage surrounding healthy tissues, thus preventing the wound 
from closing and by that delaying its healing. To address this 
problem various treatment strategies have been proposed 
worldwide depending on the healing stage and etiology of the 
wound [2, 12]. To accelerate healing process a wound should be 
debrided regularly, kept moisturized, protectedfrom further 
trauma and bacterial contamination. To achieve this, clinicians 
have been utilizing various types of dressings, gels, sprays, and 
antibiotics. These components have been used in different 
combinationsin order to optimize the wound management.  
In general, all dressings do provide a barrier to contamination. 
Due to variety of materials, there is a wide choice for a clinician to 
choose an appropriate dressing for particular woundtype [13, 14]. 
At present dressings made of polymer materials can be 
impregnated by different agents such as charcoal [15, 16], silver 
[17, 18], iodine [19, 20], and honey [21]. Properties of the material 
and the enclosed agent do determine the application of the 
dressing. The material can be presented by hydrogels, 
hydrocolloids, foams and films. Each of these materials with or 
without incorporated agents have specific mode of action aimed at 
either killing bacteria, absorbing exudate, or facilitating cell 
proliferation and wound closure.  
Gels and ointments have paste-like consistency and are 
commonly used in combination with dressings to immobilize them. 
They usually contain a single active ingredient such as 
metronidazole [22-24], honey [25, 26], silver [27], growth factors 
[28], iodine [29], or sugar [30, 31]. However, due to dilution with 
wound exudate gels and ointments become less effective and can 
cause the leakage through the dressing [32]. This in turn leads to 
more frequent re-application and dressing changes, which may not 
be cost-effective. Apart from that, their use might also provoke 
discomfort or pain.  
For infection control, topical and systemic administration of 
antibiotics has beenextensively used for infected or heavily 
contaminated wounds [33]. However, sometimes bacteria could 
develop a resistance against both topical and systemic antibiotics. 
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Often these cases have been associated with biofilms, bacterial 
communities that share common properties such as drug 
resistance [1, 34]. Therefore, there is an ongoing search for natural 
and chemical substances that can be used as an alternative to 
antibiotics. For example, it has been demonstrated that honey 
affects differently each bacterial strain, thus preventing the 
development of resistance [35]. Iodine [36], sugar [30, 32] or silver 
[18, 37-39] have also been widely used for antibacterial purposes. 
 
Wound care in Kazakhstan 
Kazakhstan is considered as a country in transition, which is a 
status of the country between developing and developed 
countries. The countryhas been ranked amongst the fastest 
growing world economies last decade. Despite the challenges of 
first years of independence, the national Health Care system 
remains the efficient and functional. It undergoes a systematic 
revision and optimization. The reforms have been focused on 
implementation of modern technologies for disease control, early 
detection, treatment and rehabilitation; strengthening the links 
between medical research and its practical applications in the 
health sector; development of international partnerships; 
integration of medical science, education and practice; monitoring 
and evaluation of health reform initiatives; and implementation of 
evidence-based medicine [40]. 
In comparison to developed countries, little is known about 
wound care system and available treatment options for chronic 
wounds in Kazakhstan. For instance, a recent study assessed public 
opinion and awareness of diabetic foot care, a type of chronic 
wound, in Almaty region [41]. The survey of 462 people identified 
the most common ten false statements given by patients, healthy 
individuals, and even medical personnel. More than 60% of 
interviewees showed poor knowledge of the subject, including 
medical personnel. Over 80% of all responders believed that there 
was no treatment available in Kazakhstan, and 69% said that 
amputation was an inevitable consequence of the treatment of 
diabetic foot. 
However, some progress in the wound care system can be 
observed from the available publications. Recently, the number of 
works in the field of wound care has increased. These articles 
indicate that the offices for diabetic foot care have been opened in 
the past few years in several cities and at least requested in others 
[42]. It must be noted he infection of diabetic wounds plays an 
important role in developing complications and worsening health 
state of the patient. In this context, the infection control and 
monitoring are essential for wound management. To achieve this, 
microbiological assessment of wound exudates has been obtained 
from patients was carried out in some hospitals [43-45]. Often 
there was no description of microbiological tests used in the 
studies [43], but in [46] Gram staining and Micro-LA-Test 
(STAPHYtest16, NEFERMtest24, CANDIDAtest21) were used to 
assess wound swabs and then develop phyto-preparations against 
identified microorganisms.  In some cases microbiological tests 
were not conducted prior to antibiotic treatment. For example, in 
Aktau [47] and in Petropavlovsk [5] doctors used loading dose of 
antibiotics for a wide range of microorganisms before both 
assessing wound micro-flora and testing patients for allergies and 
their sensitivity to these drugs. This was explained by the lack of 
time required to get the results and the urgency to start the 
treatment. The targeted antibiotics were prescribed after 
obtaining test results. 
 
Topical treatments 
Majority of publications describe case studies or case series 
regarding compounds manufactured locally or imported from 
abroad. Below is a brief summary of the types of medicines tested 
in Kazakhstan. 
 
Ointments 
Phytopreparations 
Products developed in Kazakhstan for treatment of chronic 
wounds are mostly phyto-preparations. They come in the form of 
gels and ointments prepared from plant extracts. There is limited 
information online (or in hard copy) about these compounds, and 
apparently none of them are marketed yet.  
The Institute for Phyto-chemistry located in Karaganda is 
actively involved both in the research of active components with 
regenerative ability found in plant extracts and development of 
ointments and dressings for wounds of various etiologies. The 
study by Bekmoldina [43] assessed Topolin and Calior ointments 
developed at the Institute of Phyto-chemistry for their 
antimicrobial efficacy. 408 strains from over 300 patients with 
septic and trophic wounds were identified. According to her 
analysis dominant species were Staphycoccus spp., Streptococcus 
spp., and Enterobacter spp. Both of the ointments decreased the 
number of beta-haemolytic Streptococci and Enterococcus faecalis, 
and the number of Staphylococcus aureus and Staphylococcus 
epidermidis dropped twice. However, due to superinfection the 
number of Enterobacteriaceae was increased.  
Another study compared the effect of three Kazakhstani 
phyto-preparations on acute and trophic wounds on rats [48]. All 
three preparations contained several bioactive components and 
were claimed to be multifunctional. Recently, Eurasian National 
University in Astana has claimed to have developed a new time- 
and cost-saving method for extraction of phenol compounds from 
15 different Europhorbiaceaes pp. [49]. However, the method was 
not described. Based on this technology Suttigen ointment was 
developed. Suttigen, which contains extract of Eurhobia 
Soongarica, demonstrated antimicrobial activity against strains 
extracted from septic wounds [50]. 3% Suttigen ointment 
decreased S. aureus from 10
7
-10
8
 to 1x10
4
 per 1 cm
2
. The author 
stated that this ointment cleared wounds almost twice faster and 
aided healing process better than Levomekol, or Laevomecolum  
(chloramphenicol + methyluracil) or 10% methyluracil ointments, 
which are often used in hospitals.  
The study by Mukhambetov et al. [48] on rats showed that 
healing of acute and trophic wound was better in terms of 
epithelization and formation of granulation tissue using Lipophyt 
(extract of Milfoil spissum  + oil of the mixture of several plants) or 
Topolin (Populus Nigra or Populus Balsamifera bud extract) rather 
than Suttigen. Acute wounds healed within 15-16 days using either 
Suttigen, or Lipophyt, or Topolin. Healing of trophic wounds in rats 
was more challenging. There was also no indication of wound 
closure time in the article published.  
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Table 2. The list of studies and topical treatments used to heal chronic or septic wounds in Kazakhstan 
№ Intervention Manufacturer, country Description Application Location of the study 
Market 
availability 
Ref. 
1 Pinosorb Institute for 
Phytochemistry, 
Karaganda, 
Kazakhstan 
Dressing: pine pitch with sorbent 
Trophic ulcers Karaganda Hospital 
N/A 
[53] 
2 Bialm Ointment: 30% pine pitch  N/A 
3 Levomekol Nizhpharm, Russia 
Ointment: levomycetin 
(Chloramphenicol) 
Septic wounds, 
chronic ulcers 
National Scientific-
Medical Center, 
Astana Polyclinic №6 
A [44] 
4 
Collagen film 
with cells 
Astana Polyclinic №6, 
Kazakhstan 
Dressing: collagen film with 
fibroblasts and keratinocytes 
Trophic ulcers   N/A   
5 Argosulfan Jelfa S.A., Polland 
Ointment: silver sulfathiazole 
salts 
Chronic ulcerative 
pyoderma 
Karaganda Regional 
Dermatovenerologic 
Dispensary 
A [54] 
6 Bioptron Zepter, Switzerland 
Device: polarized light in visible 
and near-infrared range 450-2000 
nm 
Trophic leg ulcers 
Research and 
Development 
Institute of 
Dermatovenerology, 
Almaty 
A [43] 
7 Topolin 
Pharmaceutical Plant, 
Karaganda, 
Kazakhstan 
Ointment: phytopreparation, 5%  Trophic ulcers 
Astana: Medical 
University, Republic 
Collection of 
Microorganisms, 
Tselinograd 
Supraregional 
Clinical Hospital. 
Kokshetau: Aqmola 
Regional Hospital  
A* 
[47] 8 Lipophyt 
Production 
Cooperation 
"Kyzylmai", Almaty, 
Kazakhstan 
Oleogelphytopreparation, 
contains beeswax 
  
A* 
9 Suttigen 
L.N.Gumilyov Eurasian 
National University, 
Astana, Kazakhstan 
Ointment in the form of powder 
that contains extract of  
Euphorbia soongarica 
N/A 
10 Regen-D 150 
Bharat Biotech 
International Ltd, India 
Gel: contains epidermal growth 
factor (EGF) 
Trophic ulcers 
Almaty Multi-Field 
Hospital 
A [50] 
11 Calior 
Institute for 
Phytochemistry, 
Kazakhstan 
Ointment: antiseptic from 
marigold 
Trophic ulcers and 
septic wounds 
Karaganda Regional 
Medical Hospital 
N/A 
[42] 
12 Topolin 
Pharmaceutical Plant, 
Karaganda, 
Kazakhstan 
Ointment: phytopreparation, 30%  A* 
13 Tachocomb Nycomed, Austria Dressing:fibrinogen and thrombin 
Septic and necrotic 
wounds 
Petropavlovsk 
Regional Hospital 
A [44] 
14 Cimekol 
S.D.Asphendiyarov 
National Medical 
University of 
Kazakhstan, Almaty, 
Kazakhstan 
Antiseptic ointment based on 
ciminal 
Septic and necrotic 
wounds 
S.D.Asfendiyarov 
National Medical 
University of 
Kazakhstan , Almaty 
N/A [51] 
* Marketed for animal use only 
 
 
Growth factors 
No data was found concerning the development of wound 
treatments using growth factors in Kazakhstan. From the imported 
ointments a case study of assessing the Indian ointment Regen-D 
150 was published [51]. Its active ingredient is epidermal growth 
factor that is potentially able to stimulate migration of cells. The 
study was conducted on 12 patients with trophic wounds. All 
patients in the treated group were healed within 4-7 weeks. Since 
the addition of growth factors into gels results in a relatively small 
increase of their efficiency in stimulating the healing process, to 
date the only one gel containing platelet derived growth factor, 
Becaplermin has been approved by FDA (U.S. Food and Drug 
Administration) [28]. The author did not comment on the results 
of the previous test studies of Regen-D and the reason this 
ointment was chosen for patient treatment in Kazakhstan.  
 
Other 
Kazakh National Medical University n.a. S.D. Asfendiyarov 
(Almaty, Kazakhstan) has developed an antiseptic ointment 
Ciminalum, or Ciminal, whose active ingredient is p-nitro-α-
chlorocinnamaldehyde, a molecule similar to levomycetin[52]. 
Ciminal was previously shown to have antimycotic activity against 
Candida and antibacterial properties against E. coli and Proteus.   
 
Biomedical devices 
Some hospitals rather use medical devices that emit light or 
sound at certain wavelengths. For instance, bioptron lamp that 
emits polarized light in the visible and infrared spectrum was 
tested [44]. This phototherapy was claimed to have regenerative, 
anti-inflammatory, and analgesic effects.   
An ultrasound device of low frequency Sonoca-400 was used 
on septic wounds [53]. Although there is no description of the 
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study, the authors claimed that granulation appears on the sixth 
day and epithelialization on the 10
th
 day. Power, time, and the 
working solution were chosen depending on the etiology and 
duration of the wound, and sensitivity of the patient. 
 
Dressings 
A collagen film impregnated with fibroblasts and keratinocytes 
was developed at the National Scientific-Medical Center in Astana, 
Kazakhstan [45]. Prior to incorporation into the dressing the 
culture of embryonic fibroblast cells was tested for carcinogenic 
properties, acquired immune deficiency syndrome (AIDS), 
hepatitis, and herpes. The collagen matrix was tested for 
pyrogenicity and toxicity. The study was conducted on 40 patients, 
20 of which were in the test group. The authors demonstrated 
higher decrease both in pain and discomfort in comparison to the 
control group. However, there was no data on wound regenerative 
progress and wound closure. 
Two imported dressings were tested at a hospital in 
Petropavlovsk, Kazakhstan [5]. Negemedjanov used a negative 
pressure compression (gauze with polymers) to reduce pressure at 
the wound site and highly adhesive dressing Tachocomb. 
Unfortunately, the study poorly described these dressings.  
Table 2 summarizes the description of the above mentioned 
treatments tested in Kazakhstan. Currently only imported products 
are commercially available on the market. 
 
Challenges and Limitations 
The major limitation of this study was the lack of online 
available publications. Many links to access online articles from the 
searched websites were inactive. Most of the medical journals 
were only available in hard copy. All found published articles were 
solely in Russian or Kazakh languages, and only a few of them 
contained abstracts in English. Moreover, majority of the journals 
included are not peer-reviewed. Table 3 shows that most of the 
studies were concentrated on the diabetic foot ulcer excluding 
other types of chronic wounds. 
Apart from that, the limitations of the studies conducted in 
Kazakhstan include the absence of randomized clinical studies, 
small sample size, and lack of control treatment. In terms of ethics, 
only patient consent letters were signed, and no indication was 
provided on ethical approval of the studies. A few case studies and 
case series were found to provide incomplete data on the study 
description, methods and results, such as patients’ age, 
description of wound, previous treatments, prescribed antibiotic 
therapy, and statistical analysis of the data. Moreover, the data in 
these studies were often given in incomplete form, which makes it 
difficult to assess the quality of the research methodology and 
draw conclusions based on the obtained results.  
The one of main problems of Kazakhstan’s Health Care system, 
and particularly wound management, is an absence of universal 
database and access of clinicians to such infromation. The 
establishing the electronic database would lead todeveloping 
optimal wound treatment protocols,improving research 
methodology, creating universal patients’ data lists and 
stimulating the knowledge exchange between clinicians across the 
country. 
 
Table 3. Areas of focus of studies in Kazakhstan 
Type of wound Studies 
Diabetic foot [5, 40, 41, 45, 55-60] 
Leg ulcer - 
Bed sore - 
Chronic wound - 
Trophic ulcer [42-44, 47, 50] 
Septic wound - 
 
 
Conclusion 
This study provides a review of current situation with wound 
care in the Republic of Kazakhstan, highlighting an importance of 
monitoring and formation of comprehensive database on wound 
statistics. Market research and literature analysis has 
demonstrated development and assessment of products and 
treatment options for wound care. For instance, the gels 
containing growth factor, different dressings and medical devices 
have been already tested in few studies. Active search and 
production of phyto-preparations is in progress at local research 
centres. However, none of the above products reached the market 
yet; and there is lack of official approval for their use on chronic 
wounds. It caused by weak interaction between science and 
industry at Kazakhstan. The situation is similar to other countries 
from Central Asia and to former Soviet Union region as well. 
According to the data available online and in hard copy, local 
hospitals have been using different treatment strategies available 
in their region. These are mostly injections, ointments and gels, 
which are applied with gauze to fix them in place. Moreover, all of 
the published interventions and treatment strategies are 
predominantly focusedon the diabetic foot excluding other types 
of chronic ulcers. 
 
Summary 
In order to improve the quality of wound care in Kazakhstan 
critical analysis and energetic actions are required. First of all, 
there is no statistical monitoring available on the prevalence of 
chronic wounds and its types, post-treatment complications, and 
associated costs from the patient and government perspectives. 
Therefore, it is necessary to develop auniversalmonitoring system 
for improvement of the system. Secondly, training of medical staff 
is required to provide patients with the best care. It is required to 
increase knowledge of the subject among medical personnel, for 
the safety of patients and prevention of cases where patients are 
prescribed wide range of unnecessary drugs. Thirdly, the import of 
new drugs and devices cannot solve the problem, but instead the 
research, development and production of novel treatments using 
resources available in the country would be most beneficial. Lastly, 
there is a huge need for using modern microbiological methods for 
easier and faster determination of wound contaminants.  
There seem to be no approved protocols for wound care in 
Kazakhstan, which requires their development and further 
application in practice. Only a few specialists tried to address this 
problem and proposed the therapeutic strategies [5, 54, 55].  
Moreover, there are additional barriers that need to be 
addressed beforehand. The lack of English language knowledge 
and lack of access to international level of science and medical 
databases restrict the ability of the medical staff and researchers 
to self-education and to keep up with the progress in the field. 
Activities aimed at increasing the overall awareness of chronic 
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wounds and available treatment options for public and medical 
staff are required. 
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